Summary
Three patients with unusual forms of gonadal dysgenesis are reported. The first had a 45, XO chromosome constitution and had secondary amenorrhoea after menstruating regularly for more than eight years. She was of short stature but secondary sexual characteristics were well developed. Laparotomy and ovarian biopsy showed streak gonads devoid of follicles. The other two patients were chromosomal mosaics. Both had two cell lines, one of which was 45, XO. The other cell line was 46, XX in one patient and 46, XXq‐ (long arm deletion of X) in the other. Both these patients had primary amenorrhoea and were of longer stature than is usual in Turner's syndrome. The literature about patients with menstrual bleeding in spite of the presence of a 45, XO chromosome constitution, either in pure or mosaic form, is briefly reviewed.
Three patients with unusual forms of gonadal dysgenesis are reported. The first had a 45, XO chromosome constitution and had secondary amenorrhoea after menstruating regularly for more than eight years. She was of short stature but secondary sexual characteristics were well developed. Laparotomy and ovarian biopsy showed streak gonads devoid of follicles. The other two patients were chromosomal mosaics. Both had two cell lines, one of which was 45, XO. The other cell line was 46, XX in one patient and 46, XXq-(long arm deletion of X) in the other. Both these patients had primary amenorrhoea and were of longer stature than is usual in Turner's syndrome. The literature about patients with menstrual bleeding in spite of the presence of a 45, XO chromosome constitution, either in pure or mosaic form, is briefly reviewed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.